Volume 116, Issue 4

Search all International Journal of Hematology articles

October 2022

24 articles in this issue

Simultaneous diagnosis of plasma cell myeloma and chronic lymphocytic leukemia on bone marrow trephine biopsy
Francesca Magnoli
Lorenzo Casiccia
Silvia Uccella
Images in Hematology 02 September 2022 Pages: 459 - 460
A rare case of multiple myeloma with Auer rod-like inclusions in plasma cells
Kenta Hayashino
Masayuki Matsuda
Toshi Imai
Images in Hematology 03 September 2022 Pages: 461 - 462
VEXAS syndrome
Kaori Uchino
Jo Kanasugi
Akiyoshi Takami
Images in Hematology 03 September 2022 Pages: 463 - 464
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
Hirohisa Nakamae
Review Article 05 August 2022 Pages: 465 - 481
Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia
Daisuke Murakami
Kensuke Matsuda
Mineo Kurokawa
Original Article 24 June 2022 Pages: 482 - 488
Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R
Ryui Miyashita
Keiko Shinozawa
Ei Kinai
Original Article 19 May 2022 Pages: 489 - 499
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)
Yoshiaki Tomiyama
Stèphane Cheze
Ricardo Viana
Original Article Open access 08 June 2022 Pages: 500 - 527
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation
Sheng-Chieh Chou
Ching-Yeh Lin
Ming-Ching Shen
Original Article 08 June 2022 Pages: 528 - 533
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system
Thao T. T. Nguyen
Minori Tamai
Takeshi Inukai
Original Article 06 May 2022 Pages: 534 - 543
Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease
Megumi Koshiishi
Ichiro Kawashima
Keita Kirito
Original Article 10 May 2022 Pages: 544 - 552
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis
Kihyun Kim
Chang-Ki Min
Kenshi Suzuki
Original Article 17 May 2022 Pages: 553 - 562
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
Satsuki Murakami
Masaki Ri
Shinsuke Iida
Original Article 14 June 2022 Pages: 563 - 569
Safety and efficacy of anagrelide in Japanese post-marketing surveillance, with subgroup analyses on the effect of previous cytoreductive therapies, age, and starting dose
Norio Komatsu
Yoshinori Hashimoto
Jovelle Fernandez
Original Article Open access 27 May 2022 Pages: 570 - 578
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases
Ami Fukumoto
Toshiki Terao
Kosei Matsue
Original Article 10 July 2022 Pages: 579 - 585
Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges
Saveria Capria
Silvia Maria Trisolini
Maurizio Martelli
Original Article 13 May 2022 Pages: 586 - 593
Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation
Takayoshi Tachibana
Masatsugu Tanaka
Hideaki Nakajima
Original Article 09 May 2022 Pages: 594 - 602
Prognostic value of pre-transplantation total metabolic tumor volume on ¹⁸fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography in relapsed and refractory aggressive lymphoma
Takeshi Sugio
Shingo Baba
Koji Kato
Original Article 14 June 2022 Pages: 603 - 611
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)
Hideki Nakayama
Chitose Ogawa
Keizo Horibe
Original Article 30 May 2022 Pages: 612 - 621
Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report
Yushi Chikasawa
Takeshi Hagiwara
Ei Kinai
Case Report 09 May 2022 Pages: 622 - 629
Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein–Barr virus infection
Masaya Maegaki
Koji Kawamura
Tetsuya Fukuda
Case Report 18 April 2022 Pages: 630 - 634
Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7
Yukihiro Matsukawa
Kenichi Sakamoto
Yoshihiro Maruo
Case Report 09 May 2022 Pages: 635 - 638
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays
Matthijs Vynck
Letter to the Editor 16 September 2022 Pages: 639 - 640
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?
Junji Suzumiya
Jun Takizawa
Correction 27 August 2022 Pages: 641 - 641
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
Yoko Edahiro
Kohshi Ohishi
Keita Kirito
Correction 27 August 2022 Pages: 642 - 643

Volume 116, Issue 4

Simultaneous diagnosis of plasma cell myeloma and chronic lymphocytic leukemia on bone marrow trephine biopsy

A rare case of multiple myeloma with Auer rod-like inclusions in plasma cells

VEXAS syndrome

Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide

Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia

Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R

Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)

Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation

Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system

Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis

Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma

Safety and efficacy of anagrelide in Japanese post-marketing surveillance, with subgroup analyses on the effect of previous cytoreductive therapies, age, and starting dose

Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation

Prognostic value of pre-transplantation total metabolic tumor volume on ¹⁸fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography in relapsed and refractory aggressive lymphoma

A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)

Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report

Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein–Barr virus infection

Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7

Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays

Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?

Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study

Navigation